Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 1, 2013, Pages 79-87

  Lonchel, C M ^a   Melin, P ^a   Gangoue Pieboji J ^b   Assoumou, M C O ^c   Boreux, R ^a   De Mol, P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CRPMT   (Cameroon)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE CTX M 15; BETA LACTAMASE SHV 12; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MEROPENEM; NITROFURANTOIN; TEMOCILLIN; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CARRIER; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CAMEROON; DNA SEQUENCE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CAMEROON; CARRIER STATE; CEPHALOSPORINS; DNA, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; FEMALE; HOSPITALIZATION; HOSPITALS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS, DNA;

EID: 84872601434     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1717-4     Document Type: Article

References (52)

1. Song W, Kim J, Bae IK, Jeong SH, Seo YH, Shin JH, Jang SJ, Uh Y, Shin JH, Lee MK, Lee K (2011) Chromosome-encoded AmpC and CTX-M extended-spectrum beta-lactamases in clinical isolates of Proteus mirabilis from Korea. Antimicrob Agents Chemother 55(4):1414-1419
2. Fabre L, Delaune A, Espie E, Nygard K, Pardos M, Polomack L, Guesnier F, Galimand M, Lassen J, Weill FX (2009) Chromosomal integration of the extended-spectrum beta-lactamase gene blaCTX-M-15 in Salmonella enterica serotype Concord isolates from internationally adopted children. Antimicrob Agents Chemother 53(5):1808-1816
3. Cantón R, González-Alba JM, Galán JC (2012) CTX-M enzymes: origin and diffusion. Front Microbiol 3:110
4. Rahal JJ (2000) Extended-spectrum beta-lactamases: how big is the problem? Clin Microbiol Infect 6(Suppl 2):2-6
5. Colodner R, Raz R (2005) Extended-spectrum beta-lactamases: the end of cephalosporins? Isr Med Assoc J 7(5):336-338
6. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11(6):315-317
7. Breurec S, Guessennd N, Timinouni M, Le TA, Cao V, Ngandjio A, Randrianirina F, Thiberge JM, Kinana A, Dufougeray A, Perrier-Gros-Claude JD, Boisier P, Garin B, Brisse S (2012) Klebsiella pneumoniae resistant to third-generation cephalosporins in five African and two Vietnamese major towns: multiclonal population structure with two major international clonal groups, CG15 and CG258. Clin Microbiol Infect. [Epub ahead of print]
8. Gangoué-Piéboji J (2007) Caractérisation des beta-lactamases et leur inhibition par les extraits de plantes médicinales. BICTEL/e - ULG Serveur institutionnel des thèses de doctorat
9. Gangoué-Piéboji J, Bedenic B, Koulla-Shiro S, Randegger C, Adiogo D, Ngassam P, Ndumbe P, Hächler H (2005) Extended-spectrum-beta- lactamase-producing Enterobacteriaceae in Yaounde, Cameroon. J Clin Microbiol 43(7):3273-3277
10. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10(4):867-878
11. Clinical and Laboratory Standards Institute (CLSI) (2010) Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI document M100-S20. CLSI, Wayne, PA
12. Dallenne C, Da Costa A, Decré D, Favier C, Arlet G (2010) Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 65(3):490-495
13. Pagani L, Dell'Amico E, Migliavacca R, D'Andrea MM, Giacobone E, Amicosante G, Romero E, Rossolini GM (2003) Multiple CTX-M-type extended-spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J Clin Microbiol 41(9):4264-4269
14. Bomasang ES, Mendoza MT (2003) Prevalence and risk factors associated with extended spectrum beta lactamase (ESBL) production among selected Enterobacteriaceae isolates at the Philippine General Hospital. Phil J Microbiol Infect Dis 32:151-158
15. Tonkic M, Goic-Barisic I, Punda-Polic V (2005) Prevalence and antimicrobial resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae strains isolated in a university hospital in Split, Croatia. Int Microbiol 8(2):119-124
16. Ramazanzadeh R, Mansouri M (2009) Spread of extended-spectrum beta-lactamase producing Escherichia coli clinical isolates in Sanandaj hospitals. J Biol Sci 9:362-366
17. Machado E, Coque TM, Cantón R, Novais A, Sousa JC, Baquero F, Peixe L; Portuguese Resistance Study Group (2007) High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 60(6):1370-1374
18. Severin JA, Mertaniasih NM, Kuntaman K, Lestari ES, Purwanta M, Lemmens-Den Toom N, Duerink DO, Hadi U, van Belkum A, Verbrugh HA, Goessens WH; Study Group 'Antimicrobial Resistance in Indonesia: Prevalence and Prevention' (AMRIN) (2010) Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia. J Antimicrob Chemother 65(3):465-469
19. Ahoyo AT, Baba-Moussa L, Anago AE, Avogbe P, Missihoun TD, Loko F, Prévost G, Sanni A, Dramane K (2007) Incidence of infections dues to Escherichia coli strains producing extended spectrum betalactamase, in the Zou/Collines Hospital Centre (CHDZ/C) in Benin. Med Mal Infect 37(11):746-752
20. Blomberg B, Jureen R, Manji KP, Tamim BS, Mwakagile DS, Urassa WK, Fataki M, Msangi V, Tellevik MG, Maselle SY, Langeland N (2005) High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. J Clin Microbiol 43(2):745-749
21. Seid J, Asrat D (2005) Occurrence of extended spectrum beta-lactamase enzymes in clinical isolates of Klebsiella species from Harar region, eastern Ethiopia. Acta Trop 95(2):143-148
22. Mirelis B, Navarro F, Miró E, Mesa RJ, Coll P, Prats G (2003) Community transmission of extended-spectrum beta-lactamase. Emerg Infect Dis 9(8):1024-1025
23. Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA (2004) Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci USA 101(10):3709-3714
24. Lonchel CM, Meex C, Gangoué-Piéboji J, Boreux R, Okomo Assoumou MC, Melin P, De Mol P (2012) Proportion of extended-spectrum β-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon. BMC Infect Dis 12(1):53
25. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R (2004) Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 23:163-167
26. Andriatahina T, Randrianirina F, Hariniana ER, Talarmin A, Raobijaona H, Buisson Y, Richard V (2010) High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar. BMC Infect Dis 10:204
27. Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J (2006) Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother 57(4):780-783
28. Rodríguez-Baño J, Navarro MD, Romero L, Martínez- Martínez L, Muniain MA, Perea EJ, Pérez-Cano R, Pascual A (2004) Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42:1089-1094
29. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32(8):1162-1171
30. Kuster SP, Hasse B, Huebner V, Bansal V, Zbinden R, Ruef C, Ledergerber B, Weber R (2010) Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection 38(1):33-40
31. Fam N, Leflon-Guibout V, Fouad S, Aboul-Fadl L, Marcon E, Desouky D, El-Defrawy I, Abou-Aitta A, Klena J, Nicolas-Chanoine MH (2011) CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb Drug Resist 17(1):67-73
32. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y (2006) Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42(7):925-934
33. Gangoué-Piéboji J, Koulla-Shiro S, Ngassam P, Adiogo D, Ndumbe P (2006) Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon. Afr Health Sci 6(4):232-235
34. Peirano G, van Greune CH, Pitout JD (2011) Characteristics of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli from community hospitals in South Africa. Diagn Microbiol Infect Dis 69(4):449-453
35. Drieux L, Brossier F, Duquesnoy O, Aubry A, Robert J, Sougakoff W, Lecso-Bornet M, Jarlier V (2009) Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamase-producing Escherichia coli in a large French teaching hospital. Eur J Clin Microbiol Infect Dis 28(5):491-498
36. Silva J, Aguilar C, Becerra Z, López-Antuñano F, García R (1999) Extended-spectrum beta-lactamases in clinical isolates of enterobacteria in Mexico. Microb Drug Resist 5(3):189-193
37. Ho PL, Poon WW, Loke SL, Leung MS, Chow KH, Wong RC, Yip KS, Lai EL, Tsang KW; COMBAT study group (2007) Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother 60(1):140-144
38. Ndugulile F, Jureen R, Harthug S, Urassa W, Langeland N (2005) Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania. BMC Infect Dis 5:86
39. Ehlers MM, Veldsman C, Makgotlho EP, Dove MG, Hoosen AA, Kock MM (2009) Detection of blaSHV, blaTEM and blaCTX-M antibiotic resistance genes in randomly selected bacterial pathogens from the Steve Biko Academic Hospital. FEMS Immunol Med Microbiol 56(3):191-196
40. Touati A, Brasme L, Benallaoua S, Madoux J, Gharout A, de Champs C (2008) Enterobacter cloacae and Klebsiella pneumoniae isolates producing CTX-M-15 recovered from hospital environmental surfaces from Algeria. J Hosp Infect 68(2):183-185
41. Touati A, Benallaoua S, Forte D, Madoux J, Brasme L, de Champs C (2006) First report of CTX-M-15 and CTX-M-3 beta-lactamases among clinical isolates of Enterobacteriaceae in Béjaia, Algeria. Int J Antimicrob Agents 27(5):397-402
42. Touati A, Benallaoua S, Djoudi F, Madoux J, Brasme L, De Champs C (2007) Characterization of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from hospital environments in Algeria. Microb Drug Resist 13(2):85-89
43. Olowe OA, Grobbel M, Büchter B, Lübke-Becker A, Fruth A, Wieler LH (2010) Detection of bla(CTX-M-15) extended-spectrum beta-lactamase genes in Escherichia coli from hospital patients in Nigeria. Int J Antimicrob Agents 35(2):206-207
44. Frank T, Arlet G, Gautier V, Talarmin A, Bercion R (2006) Extended-spectrum beta-lactamase-producing Enterobacteriaceae, Central African Republic. Emerg Infect Dis 12(5):863-865
45. Dahmen S, Bettaieb D, Mansour W, Boujaafar N, Bouallègue O, Arlet G (2010) Characterization and molecular epidemiology of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian University Hospital. Microb Drug Resist 16(2):163-170
46. Damjanova I, Tóth A, Pászti J, Bauernfeind A, Füzi M (2006) Nationwide spread of clonally related CTX-M-15-producing multidrug-resistant Klebsiella pneumoniae strains in Hungary. Eur J Clin Microbiol Infect Dis 25(4):275-278
47. Valenzuela de Silva EM, Mantilla Anaya JR, Reguero Reza MT, González Mejía EB, Pulido Manrique IY, Darío Llerena I, Velandia D (2006) Detection of CTX-M-1, CTX-M-15, and CTX-M-2 in clinical isolates of Enterobacteriaceae in Bogota, Colombia. J Clin Microbiol 44(5):1919-1920
48. Duval V, Maiga I, Maiga A, Guillard T, Brasme L, Forte D, Madoux J, Vernet-Garnier V, De Champs C (2009) High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali. Antimicrob Agents Chemother 53(11):4957-4958
49. Ramdani-Bouguessa N, Mendonça N, Leitão J, Ferreira E, Tazir M, Caniça M (2006) CTX-M-3 and CTX-M-15 extended-spectrum beta-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria. J Clin Microbiol 44(12):4584-4586
50. Gangoué-Piéboji J, Miriagou V, Vourli S, Tzelepi E, Ngassam P, Tzouvelekis LS (2005) Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a blaCTX-M-15-carrying element. Antimicrob Agents Chemother 49(1):441-443
51. Kariuki S, Corkill JE, Revathi G, Musoke R, Hart CA (2001) Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya. Antimicrob Agents Chemother 45(7):2141-2143
52. Mohamed Al-Agamy MH, El-Din Ashour MS, Wiegand I (2006) First description of CTX-M beta-lactamase-producing clinical Escherichia coli isolates from Egypt. Int J Antimicrob Agents 27(6):545-548